|

Penpulimab Injection Clinical Trials

3 actively recruiting trials

Also known as: AK-105

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

  • The First Affiliated Hospital with Nanjing Medical University1
  • Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University1
  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1

Indications

  • Cancer3
  • Gastrointestinal Diseases1
  • Digestive System Diseases1
  • Advanced Pancreatic Cancer1
  • Gastrointestinal Neoplasms1

Other3 trials

Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Phase 1/2
Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC
Phase 2
XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.